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Abstract
 
The V(D)J recombination/DNA repair factor Artemis belongs to the metallo-
 
 
 
-lactamase (
 
 
 
-Lact)
superfamily of enzymes. Three regions can be defined within the Artemis protein sequence:
(a) the 
 
 
 
-Lact homology domain, to which is appended (b) the 
 
 
 
-CASP region, specific of
members of the 
 
 
 
-Lact superfamily acting on nucleic acids, and (c) the COOH-terminal domain.
Using in vitro mutagenesis, here we show that the association of the 
 
 
 
-Lact and the 
 
 
 
-CASP
regions suffices for in vivo V(D)J recombination of chromosome-integrated substrates. Single
amino acid mutants point to critical catalytic residues for V(D)J recombination activity. The
results presented here define the 
 
 
 
-Lact/
 
 
 
-CASP domain of Artemis as the minimal core catalytic
domain needed for V(D)J recombination and suggest that Artemis uses one or two Zn(II) ions
to exert its catalytic activity, like bacterial class B 
 
 
 
-Lact enzymes hydrolyzing 
 
 
 
-lactam compounds.
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Introduction
 
V(D)J recombination, the mechanism by which immuno-
globulin and T cell receptor variable domain encoding
genes are assembled, is initiated through the introduction of
a DNA double strand break (DNA-dsb) by the lymphoid-
specific factors RAG1 and RAG2 (for a review of V(D)J
recombination see references 1 and 2). RAG1 and RAG2
recognize recombination signal sequences (RSS) that flank
all variable (V), diversity (D), and joining (J) gene units and
introduce the DNA-dsb at the border of the RSS. The repair
of the DNA gap is then achieved by at least six proteins that
belong to the nonhomologous end joining apparatus:
Ku70/Ku80, DNA-dependent protein kinase catalytic sub-
unit (DNA-PKcs), XRCC4/LigaseIV, and Artemis (3).
The DNA-dsb is first recognized by the DNA-PK complex
formed by the Ku70/Ku80 heterodimer, which binds to
DNA ends, and the DNA-PKcs, which belongs to the PI3
family of kinases and requires DNA association for enzymatic
activity. Artemis then probably opens the hairpin structures
at coding ends (CE) before ligation (see below). Finally, the
XRCC4/DNA–LigaseIV complex catalyzes the ligation
step. Several animal models (2, 4) and human radiosensitive
SCID (RS-SCID; references 3 and 5) have demonstrated
the absolute prerequisite for these factors in terminating the
V(D)J recombination process. Indeed, a defect in any non-
homologous end joining factor results in a complete block
of both B and T cell maturation, leading to SCID in all of
these situations. However, in human Artemis-deficient
patients (5), in Artemis KO mice (4), and to a lesser extent
in the murine SCID condition (6), the signal joints are
qualitatively and quantitatively unaffected, whereas the
coding joint formation is severely impaired, suggesting a
subtle difference in the resolution of the two RAG1/
RAG2-generated DNA intermediates. Before DNA repair,
CE are present on the chromosome as hairpin-sealed struc-
tures (7), whereas signal ends are excised from the chromo-
some as blunt and 5
 
  
 
phosphorylated termini (8, 9). Artemis,
which is mutated in RS-SCID patients, was therefore postu-
lated to represent the missing factor accountable for opening
the hairpin at CE before religation (3). Ma et al. (10) dem-
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onstrated that Artemis possesses an exonuclease activity in
vitro. Moreover, when complexed to and phosphorylated
by DNA-PKcs, Artemis’s specificity switches to an endo-
nucleolytic activity. Under these circumstances, Artemis is
capable of opening RAG1/RAG2-generated hairpins at
CE in vitro (10). This enzymatic activity for Artemis was
further accredited by the observation of hairpin-sealed CE
in thymocytes from Artemis KO mice (4).
Based on protein sequence analysis, Artemis defines a
separate evolutionary conserved group of enzymes (the
 
 
 
-CASP family) within the metallo-
 
 
 
-lactamase (
 
 
 
-Lact)
superfamily (3, 11). In this study we used an in vitro mu-
tagenesis approach to dissect the role of the 
 
 
 
-Lact and
 
 
 
-CASP domains of Artemis with regard to V(D)J recom-
bination and DNA repair after ionizing radiation.
 
Materials and Methods
 
Plasmids and In Vitro Mutagenesis.
 
Artemis cDNA was cloned
into pGEM (pArte) for subsequent mutagenesis. Full-length (FL)
and 
 
 
 
-Lact/
 
 
 
-CASP (Met1-Ser385) domains of Artemis were
subcloned in pCDNA1.1 (Invitrogen) together with a COOH-
terminal His(6
 
 
 
)-myc tag. FL Artemis cDNA was subcloned in
frame with glutathione-
 
S
 
-transferase (GST) in pEBG together
with a COOH-terminal His(6
 
 
 
)-myc Tag (pEBG-myc). In vitro
mutagenesis was performed using the Quick-Change (Stratagene)
system on pArte construct according to the manufacturer’s rec-
ommendations. Mutagenized Artemis coding sequences were
then subcloned into pEBG-myc.
 
Western Blot and Immunoprecipitation.
 
293T cells were trans-
fected with empty vector or the various GST-Artemis-myc–
expressing plasmids. Expression of the various mutants was as-
sessed 48 h after transfection by Western blotting (WB) on whole
cell lysate using anti-myc (clone 9E10; Santa Cruz Biotechnology
Associates, Inc.) antibody. For immunoprecipitation studies, cells
were washed in 1
 
 
 
 PBS and incubated for 30 min in lysis buffer
(50 mM Tris, pH 7.5, 0.1% Triton X-100, 100 mM NaCl, 1 mM
DTT, 10% glycerol, 15 mM EGTA, 10 mM NaF, 5 
 
 
 
g/ml pep-
statin, leupeptin, 1 
 
 
 
g/ml aprotinin) on ice. After centrifugation,
the anti-myc antibody (clone 9E10) and protein G–Sepharose
were added and the mixes were placed on a wheel at 4
 
 
 
C for
12 h. After washing, the beads were eluted in sample loading
buffer. The samples were analyzed by WB with anti–DNA-PKcs
(Ab-2 [25–4]; Neomarkers) and anti-GST (Z-5; Santa Cruz Bio-
technology Associates, Inc.) antibodies.
 
V(D)J Recombination on Chromosomal Substrates.
 
The GUETEL/
RSS and OTEL/RSS V(D)J recombination reporter cell lines
were derived by retroviral infection of the Artemis-deficient
GUETEL and control OTEL cells with MX-RSS-GFP/ires-
huCD4 retrovirus (provided by M. Schlissel, University of Cali-
fornia, Berkeley, CA; reference 12). These two cell lines are
SV40-transformed, telomerase-immortalized skin fibroblasts. The
GUETEL cells were obtained from a previously described (P15 in
reference 3) Artemis-deficient patient. Retroviral supernatants
were produced by transient transfection of Phoenix-Ampho cells
(provided by G. Nolan, Stanford University School of Medicine,
Standford, CA) as previously described (13). V(D)J recombina-
tion is induced transiently by the cotransfection of 3 
 
 
 
g HuRag1
and 2.4 
 
 
 
g HuRag2 expression plasmids (based on pcDNA1.1)
expressing FL human proteins under the CMV promoter using
electroporation. 2.5 
 
 
 
g human Artemis expression construct is
added for complementation studies. 72 h after transfection, the
cells are stained with phycoerythrin-conjugated anti-CD4 anti-
body and analyzed by FACS
 
® 
 
for green fluorescent protein (GFP)
fluorescence (FL1) and CD4 expression (FL2). The percentage of
recombination corresponds to the fraction of GFP
 
  
 
cells amongst
CD4
 
  
 
cells.
 
Radiosensitivity Analysis.
 
Artemis coding regions (FL or 
 
 
 
-Lact/
 
 
 
-CASP domain) were subcloned into the pMND-MFG retrovi-
ral vector (provided by D. Kohn, Children’s Hospital Los Ange-
les, Los Angeles, CA) upstream of an ires-GFP cassette under the
regulation of the virus LTR (see Fig. 5 A). Retroviral superna-
tants were used to transduce a primary fibroblast cell line from an
RS-SCID patient, resulting in a mixed population with a given
percentage of transduced (GFP
 
 
 
) and untransduced (GFP
 
 
 
) cells.
The mixed populations were subjected to increasing doses of
 
  
 
ray irradiation (0–2 Gy) and the percentage of GFP
 
  
 
cells was
evaluated by FACS
 
® 
 
analysis 15 d after irradiation to assess the se-
lective advantage conferred by the introduction of the various
forms of Artemis. The index of GFP
 
  
 
cells after irradiation is cal-
culated upon comparison with the percentage of GFP
 
  
 
cells in
the unirradiated samples.
 
Results and Discussion
 
We defined three separate regions in the Artemis protein
(Fig. 1 A) based on analysis of its sequence (3, 11). The
most NH
 
2
 
-terminal region, from the initiation methionine
up to R155, encoded by exons 1–6, corresponds to the
 
 
 
-Lact homology domain. This region presents four out of
Figure 1. Analysis of artemis protein sequence. (A) Artemis is composed
of three identifiable regions, the  -Lact homologous region (amino acids
1–155), the associated  -CASP domain (amino acids 156–385), and the
COOH-terminal region (amino acids 386–692). Regions of the Artemis
sequence used for functional experiments are indicated. (B) Critical residues
(in bold) that compose the catalytic site of bacterial  -Lacts are conserved
in Artemis. The numbering is according to the Artemis protein sequence.
Three residues (D165, H319, and V341) represent the signature of the
 -CASP domain. 
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the five conserved motives (Fig. 1 B, I to IV), constituting
the 
 
 
 
-Lact–active center and mostly consisting of histidine
and aspartic acid residues that participate in zinc coordina-
tion and hydrolysis reaction characteristic of enzymes of
this superfamily (14). This region is followed by the
 
 
 
-CASP region (11), which is encoded by exons 7–13, up
to S385. This region is always associated with 
 
 
 
-Lact mo-
tives I to IV within nucleic acid–processing enzymes of the
 
 
 
-CASP family such as murine SNM1, yeast PSO2, or the
cleavage- and polyadenylation-specific factor. Two highly
conserved residues (D165 and H319 in Artemis) constitute
an outstanding signature of the 
 
 
 
-CASP domain, whereas a
third one (V341 in Artemis) appears to be specific of the
kind of substrate that is highly conserved as a valine or a
histidine in proteins acting on DNA or RNA, respectively
(Fig. 1 B). Importantly, D165 or H319 in the 
 
 
 
-CASP–
specific region could represent the fifth motif of the 
 
 
 
-Lact
signature, which is not present in the 
 
 
 
-Lact homology re-
gion per se. We propose that the 
 
 
 
-CASP region partici-
pates with the 
 
 
 
-Lact region in forming the catalytic site of
Artemis. Lastly, the exon 14–encoded carboxy terminal
half of the protein, from E386 to T692, designated hereaf-
ter as “C-Ter,” appears as a separate domain.
 
Definition of the Artemis Catalytic Core Required for V(D)J
Recombination.
 
We undertook deletional and single amino
acid mutagenesis analyses to define the core catalytic region
of Artemis in vivo. Given recent studies demonstrating a
different RAG1/RAG2 requirement for V(D)J recombina-
tion on extrachromosomal versus chromosomal substrates
(12, 15–17), we analyzed the function of Artemis in the
context of in-chromosome V(D)J recombination by using
the experimental strategy developed by Liang et al. (12). A
chromosomal V(D)J recombination substrate was stably in-
tegrated in the Artemis-deficient GUETEL (GUETEL/
RSS cells) and control OTEL (OTEL/RSS) cell lines by
means of retroviral infection (Fig. 2). pMX-RSS-GFP/
ires-huCD4 (Fig. 2 A) is a retroviral construct in which an
RSS-flanked GFP cassette is inserted in reverse transcrip-
tional orientation relative to the 5
 
  
 
LTR promoter. Cells
carrying the V(D)J reporter cassette are detected through
the cell surface expression of huCD4 (Fig. 2 B). V(D)J re-
combination of the construct is induced through the tran-
sient transfection of RAG1/RAG2 expression plasmids,
which results in the inversion of the GFP cassette leading
to green fluorescence expression. The control OTEL/RSS
cells recombine the substrate (1.44% GFP
 
 
 
/CD4
 
 
 
) in the
presence of both RAG1 and RAG2 but not in the sole
presence of RAG1 (0.07%) as expected, and the addition of
exogenous Artemis does not increase the recombina-
tion frequency (1.79%). In contrast, the Artemis-deficient
GUETEL/RSS cells poorly rearrange the substrate in the
presence of RAG1 and RAG2 (0.22%), a defect that is fully
complemented by the addition of exogenous Artemis
(1.36%). Interestingly, the recombination frequency of
GUETEL/RSS cells in the absence of Artemis is signifi-
cantly above background level (0.22 vs. 0.03%) in accord
with the previously reported leakiness of Artemis-deficient
cells in mice (4, 18). Sequencing the V(D)J coding joints
from GUETEL/RSS cells transfected in the absence of Ar-
temis revealed a high frequency of 1–8-bp-long P nucle-
otide addition (Fig. 3 B), a situation previously associated
with Artemis deficiency in murine ES cells but not found
in control, V(D)J-proficient, OTEL/RSS cells (Fig. 3 A).
The addition of Artemis completely restores the quality of
the V(D)J junctions in GUETEL/RSS cells (Fig. 3 C). The
integrated results of six experiments show that the relative
Figure 2. V(D)J recombination on chromosomal substrates. (A) structure of the MX-RSS-EGFP/ires-HuCD4 construct before and after inversional
V(D)J recombination. In the germline configuration, an inverted EGFP cassette is flanked by two RSS. Upon V(D)J recombination, the EGFP gene
is reoriented and productively transcribed from the LTR promoter. (B) Wild-type OTEL- and Artemis-deficient GUETEL cells were transduced with
MX-RSS-EGFP/ires-HuCD4 resulting in 43 and 80% CD4  cells, respectively. Recombination of the substrates is initiated by transient transfection of
RAG1/RAG2 expression constructs with or without Artemis. (C) Mean results of 6 V(D)J recombination experiments in GUETEL/RSS cells. The V(D)J
recombination activity is calculated relative to the recombination frequency obtained with RAG1 (R1), RAG2 (R2), and wild-type Artemis (Arte wt). 
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level of V(D)J recombination (Fig. 2 C) and the quality of
the resulting CJ (Fig. 3 D) is identical whether FL or
 
 
 
-Lact/
 
 
 
-CASP domain-only forms of Artemis are used to
complement the GUETEL/RSS cells. Therefore, we con-
clude that the 
 
 
 
-Lact/
 
 
 
-CASP region of Artemis carries
the catalytic activity required for V(D)J recombination.
 
Definition of Critical Catalytic Residues for Artemis Function
In Vivo.
 
The catalytic residues that define the two Zn(II)-
binding pockets of class B 
 
 
 
-Lacts concord to a highly con-
served consensus signature: [HxHxD]...[H]...[C]...[H] (14).
As most of these residues are conserved in Artemis (Fig. 1
B), we analyzed their role in Artemis function through in
vitro mutagenesis. All engineered mutants were normally
expressed and retained the capacity to interact with DNA-
PKcs as judged by coimmunoprecipitation assay (Fig. 4 A).
One representative experiment (Fig. 4 B) demonstrates that
the basal V(D)J recombination activity in GUETEL/RSS
cells (0.12%) is fully complemented by both Artemis (0.99%)
or GST-Artemis (1.25%) expression constructs despite the
previously reported reduced activity of a GST-Artemis fu-
sion protein in vitro (10). GST-Artemis alone did not in-
duce V(D)J recombination (0.01%) as expected. The inte-
grated results of four experiments is shown in Fig. 4 C.
Based on sequence analysis, the H33/H35/H115 triad in
Artemis was predicted to correspond to the ligands of the
first zinc (Zn1) of the binuclear Zn(II) center (Fig. 4 D).
Accordingly, replacement of these residues with alanine
strongly compromises the Artemis activity in all three mu-
tants (Fig. 4 C). As a control, the mutant H151A, which af-
fects a nonconserved His residue outside of the putative cat-
alytic site, does not alter Artemis function. In the structure
of class B enzymes as shown for 
 
Bacillus cereus
 
 in Fig. 4 D,
the second zinc (Zn2) is coordinated by an aspartic acid, a
histidine and a cysteine, and by two water molecules. The
Asp residue is conserved in Artemis and its replacement by
alanine (D37A) abolishes Artemis’ activity. The Cys (Cys168
in 
 
B. cereus
 
) is conserved in class B 
 
 
 
-Lacts except for L1 en-
zyme of 
 
Stenotrophomonas maltophilia
 
 where it is replaced by a
Ser at position 185, which is not a ligand of the zinc ion (14,
19). Instead, His89 provides the fifth Zn2 ligation in the L1
structure, next to the Asp88 residue in motif II (Figs. 1 B
and 4 D). The Cys residue is not present in Artemis either,
where Asp136 replaces it. Although this residue could sub-
stitute for the Cys in Zinc binding, it is interesting to note
that Artemis also contains a His at position 38 in motif II
that could participate in the Zn(II) coordination (Figs. 1 B
and 4 D). To discriminate between these two possibilities,
we analyzed the function of Artemis carrying alanine muta-
Figure 3. Sequence analysis of V(D)J coding joints. Coding joints were PCR amplified and sequenced from rearranged OTEL/RSS and GUETEL/
RSS cells. P nucleotides are indicated in bold. Sequences were obtained from two independent experiments for OTEL/RSS transfected with R1/R2 (A)
and three independent transfections for GUETEL/RSS transfected with R1/R2 (B), R1/R2/Artemis-FL (C), and R1/R2/ -Lact- -CASP (D). 
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tions at these two positions. Although H38A mutant is fully
active, D136A has lost most of the catalytic activity (Fig. 4
C). Therefore, this result suggests that the putative second
Zn(II) center of the Artemis catalytic site would adopt a
structure similar to that of the 
 
B. cereus
 
 enzyme with Asp136
substituting the conserved Cys (Figs. 1 B and 4 D).
The last residue of the second Zn(II) center (H210 in 
 
B.
cereus
 
) is not easily recognized in members of the 
 
 
 
-CASP
family, including Artemis as previously noticed (11). How-
ever, it could correspond to either one of the two highly
conserved anchoring residues that constitute the signature of
the 
 
 
 
-CASP region, the Asp165 or His319 (Figs. 1 B and 4
D). Unfortunately, the loss of Artemis function in both
D165A and H319A mutants does not allow discriminating
between these two hypotheses. Altogether, these results
demonstrate that Artemis has conserved not only the 
 
 
 
-lac-
tamase fold but also the functional catalytic residues and,
therefore, suggest that the hairpin opening activity of Arte-
mis described by Ma et al. (10) proceeds through an enzy-
matic mechanism similar to the one described for bacterial
class B 
 
 
 
-Lacts. We propose a model in which Artemis may
possess a structure closest to that of the 
 
 
 
-Lact enzyme of 
 
B.
cereus
 
 to account for the two putative Zn(II)-binding sites
(Fig. 4 D). Another mutant, D17A, has also lost catalytic ac-
tivity. Although this residue does not directly participate in
the two Zn(II) pockets, its high degree of conservation
among all 
 
 
 
-Lacts suggested that it was important for enzy-
matic activity (14). Lastly, it was hypothesized that the Val/
His341 could discriminate between DNA- and RNA-pro-
cessing enzymes, respectively (11). However, the replace-
ment of Val341 by alanine, histidine, or serine does not
compromise the catalytic function of Artemis.
 
The COOH-terminal Region of Artemis Is Required for
DNA Repair after Ionizing Radiation.
 
Although the 
 
 
 
-Lact/
 
 
 
-CASP domain of Artemis suffices for V(D)J recombina-
tion, the high degree of sequence conservation in the C-Ter
domain (unpublished data) suggests that this region could
have an important function, perhaps in relation with the re-
pair of ionizing radiation-induced DNA damages. We ana-
lyzed the capacity of the FL and 
 
 
 
-Lact/ -CASP forms of
Artemis to complement the increased radiosensitivity of
RS-SCID primary fibroblasts. FL and  -Lact/ -CASP ver-
sions of Artemis were introduced in RS-SCID primary fi-
broblasts by retroviral infection (Fig. 5). The resulting mixes
Figure 4. V(D)J recombinase activity of in vitro–generated Artemis mutants. (A) All mutants are expressed in 293T cells and retain their capacity
to interact with DNA-PKcs. (B) FACS® analysis of GUETEL/RSS cells transiently transfected with RAG1, RAG2, and the various Artemis mutants.
The percent of recombination refers to the frequency of EGFP  cells among the CD4  cells. (C) Integrated results of four experiments showing the
relative V(D)J recombination activity of the mutants relative to the recombination frequency using GST-Arte. (D) Hypothetical model for the structure
of the catalytic site of Artemis. This model is based on the structure of the B. cereus and S. maltophilia  -Lacts as adapted from Wang et al. (reference 14;
PDB codes: 1BC2 and 1SML, respectively). Gray and red spheres indicate the position of zinc and water oxygen atoms, respectively. Shaded areas corre-
spond to the two Zn(II)-binding domains. The green star indicates the position of the fifth Zn2 ligand, which may correspond to a water molecule, or to
a conserved amino acid of the  -CASP region (possibly D165).Core Catalytic Domain of Artemis 320
of transduced (enhanced GFP [EGFP] ) and untransduced
(EGFP ) cells were subjected to increasing doses of   irradi-
ation (0–2 Gy) and the frequency of EGFP  cells was deter-
mined 15 d later (Fig. 5 B). Although in sample using empty
ires-EGFP retroviral vector the frequency of green fluores-
cent cells does not vary (index 1.18   0.03 at 2 Gy), this
value increases in a dose-dependent manner when using the
Artemis (FL)-ires-EGFP virus, with an index of 1.81  
0.006 after irradiation at 2 Gy. This demonstrates that Arte-
mis complements the increased radiosensitivity phenotype
of RS-SCID cells, conferring a growth advantage of the
transduced (GFP ) cells. In contrast, the same experiment
using the Artemis  -Lact/ -CASP domain-only does not
result in any growth advantage of the transduced cells (index
1.12   0.01 at 2 Gy). Western blot analysis of the trans-
duced cell populations (Fig. 5 C) revealed a much weaker
expression of the truncated version of Artemis compared
with FL. This decreased expression is apparently not caused
by a difference in the transcription rate of the constructs as
judged by the mean fluorescence intensity of GFP  cells
(unpublished data), but possibly by a decrease in protein sta-
bility. However, the barely detectable expression of endog-
enous Artemis protein in wild-type fibroblasts by WB (un-
published data) suggests that the low level of truncated
Artemis expression in these experiments, which is already
above physiological level, may not be directly and/or solely
responsible for the absence of complementation of increased
radiosensitivity of RS-SCID cells.
In conclusion, our study demonstrates that Artemis can be
divided into two critical regions. The  -Lact homology do-
main associated with the  -CASP region defines the cata-
lytic site stricto sensu, which probably exerts its enzymatic
activity through Zinc coordination like other  -Lact en-
zymes. This catalytic site suffices on its own to perform
V(D)J recombination. However, this “core” of Artemis is
not sufficient to guarantee the repair of DNA damages
caused by ionizing radiation. The COOH-terminal region
may play an important role through stabilization of the pro-
tein. Another explanation could be that the DNA damage
during V(D)J recombination and after ionizing radiation are
qualitatively different and therefore may not require exactly
the same regions of Artemis for their repair. Although the
precise function of Artemis in V(D)J recombination seems to
be the opening of hairpin structures at CE (10), hairpin for-
mation is not a common consequence of ionizing radiation.
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